Guangdi Chu
Impact in
-
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
-
- Ferroptosis and cancer prognosis
- Renal cell carcinoma treatment
Papers in
-
- Ferroptosis and cancer prognosis 2
- Renal and Vascular Pathologies 2
- Surgery 4
- Bladder and Urothelial Cancer Treatments 2
- Surgical Simulation and Training 1
- Co-authors
- Haitao Niu (8 shared papers)Xiaoyu Ji (3 shared papers)Yonghua Wang (3 shared papers)Wei Jiao (4 shared papers)Xuecheng Yang (3 shared papers)Mingxin Zhang (3 shared papers)Guanqun Zhu (1 shared paper)Zhiqiang Li (1 shared paper)
In The Last Decade
Guangdi Chu
23 papers receiving 135 citations
Peers
Comparison fields: 5 of 42
- Cancer Research 25
- Pulmonary and Respiratory Medicine 35
- Health Informatics 1
- Oncology 17
- Immunology 11
Countries citing papers authored by Guangdi Chu
This map shows the geographic impact of Guangdi Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangdi Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangdi Chu more than expected).
Fields of papers citing papers by Guangdi Chu
This network shows the impact of papers produced by Guangdi Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangdi Chu. The network helps show where Guangdi Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Guangdi Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 51 | |
| 2 | 2021 | 11 | |
| 3 | 2020 | 11 | |
| 4 | 2023 | 9 | |
| 5 | 2021 | 8 | |
| 6 | 2025 | 7 | |
| 7 | 2020 | 7 | |
| 8 | 2023 | 4 | |
| 9 | 2025 | 3 | |
| 10 | 2025 | 3 | |
| 11 | 2025 | 3 | |
| 12 | 2025 | 3 | |
| 13 | 2024 | 3 | |
| 14 | 2025 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2025 | 2 | |
| 18 | 2023 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 1 |
About Guangdi Chu
Guangdi Chu is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Health Informatics and Artificial Intelligence, having authored 27 papers that have together received 138 indexed citations. Recurring topics across this work include Artificial Intelligence in Healthcare and Education (3 papers), Ferroptosis and cancer prognosis (2 papers), Renal and Vascular Pathologies (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Genetic factors in colorectal cancer (2 papers), AI in cancer detection (2 papers), Academic integrity and plagiarism (1 paper) and Surgical Simulation and Training (1 paper). The work is most often cited by research in Cancer Research (25 citations), Pulmonary and Respiratory Medicine (35 citations), Health Informatics (1 citation), Oncology (17 citations) and Immunology (11 citations). Guangdi Chu has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Haitao Niu, Xiaoyu Ji, Yonghua Wang, Wei Jiao, Xuecheng Yang, Mingxin Zhang, Guanqun Zhu, Zhiqiang Li, Ting Xu and Ye Liang. Their work appears in journals such as International Journal of Surgery, Surgical Endoscopy, European Urology, Cancer Letters and BMC Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.